U.S. IT Stock News

In the past, several law firms, including Levi & Korsinsky, Rosen Law Firm and Holzer & Holzer, announced securities class action lawsuits against Regencell Bioscience Holdings after the company disclosed a Department of Justice subpoena into trading of its ordinary shares. The cases focus on allegations that Regencell issued materially false or misleading statements and failed to disclose its vulnerability to market manipulation during the October 28, 2024 to October 31, 2025 period...

Recent commentary around Sensata Technologies Holding (ST) has centered on its shift away from traditional auto supply toward higher margin industrial and aerospace markets, a change led by its new CEO and reinforced by portfolio streamlining. See our latest analysis for Sensata Technologies Holding. Recent portfolio changes and the shift toward industrial and aerospace markets appear to be feeding into sentiment, with the share price at US$50.17 and a 90 day share price return of 49.58%,...

Jacobs Solutions: recent returns and business mix Jacobs Solutions (J) has drawn investor attention after a period of mixed share performance, with short term returns soft yet longer multiyear figures remaining positive. This has prompted closer focus on how its global consulting and infrastructure operations stack up. See our latest analysis for Jacobs Solutions. At a share price of US$119.96, Jacobs Solutions has seen its short term momentum soften, with the share price return declining...

Why Avnet Stock Is On Investors’ Radar Avnet (AVT) has drawn fresh attention after recent gains, with the stock closing at US$87.05 and posting solid total returns over the past year, the past 3 months, and the past month. See our latest analysis for Avnet. The recent move to US$87.05 comes after a strong run, with a 30 day share price return of 6.04% and a 1 year total shareholder return of 72.78%. This points to momentum that investors are still watching closely. If Avnet’s run has you...

Joby Aviation has already begun flying its electric air taxis over major cities and, through a White House-backed program, secured opportunities to operate in 11 US states as part of broader efforts to expand sustainable, low-emission air transport. These developments position Joby at the center of the emerging electric aircraft market, where vertical takeoff and landing platforms are expected to play a leading role in future urban and regional mobility networks. Next, we’ll examine how...

Recent performance snapshot for Allstate (ALL) Allstate (ALL) has seen mixed share performance, with the stock down about 2.7% over the past day but up roughly 3.8% over the past week and 5.5% year to date. Over the past month, the stock is up about 0.9%, and over the past 3 months it has gained roughly 3.6%. This provides investors with a reference point for how recent moves compare with longer holding periods. For context, Allstate reports annual revenue of about US$68.2b and net income of...

Recent performance snapshot for StoneCo (NasdaqGS:STNE) StoneCo (NasdaqGS:STNE) has drawn fresh attention after a period of mixed share performance, with the stock up 1.6% over the past day but down over the past week, month, past 3 months, and year to date. In this context, investors are weighing StoneCo’s current share price of $10.57, its recent annual revenue of R$13,535.522 and net income of R$3,625.311, along with a mid-range value score of 5 and an intrinsic discount estimate of...

Recent share performance context Novo Nordisk (NYSE:NVO) has been on many investors’ radar after a period of mixed share performance, with the stock down over the past month but higher over the past 3 months. At a last close of US$41.02, the stock is also lower over the year to date and the past year, while the 5 year total return remains positive. This gives investors a wide range of recent return experiences to consider. See our latest analysis for Novo Nordisk. Short term momentum has...

Investors may be wondering whether Rexford Industrial Realty is starting to look attractively priced, or if the current share price still leaves little room for upside. The stock closed at US$33.96 and has been under pressure recently, with the share price down 2.1% over the past week, 6.4% over the past month, 13.0% year to date and 2.8% over the last year. This extends a 25.2% decline over three years and 33.0% over five years. Recent coverage has focused on how industrial real estate...

Celldex Therapeutics overview and recent stock context Celldex Therapeutics (CLDX) has drawn investor attention after recent trading, with the stock closing at US$28.56. Short term moves included a 0.2% decline over the past day and a 5.2% pullback over the past week. See our latest analysis for Celldex Therapeutics. The recent pullback, including a 16% decline in the 1 month share price return, sits against a stronger backdrop, with a 1 year total shareholder return of 37.9% but weaker 3 and...

Disc Medicine recently reported updated Phase 2 RALLY-MF data showing that its investigational drug DISC-0974 produced meaningful improvements in anemia outcomes for myelofibrosis patients, while also launching a U.S. expanded access program for bitopertin in erythropoietic and X-linked protoporphyria. At the same time, the company is facing an FDA Complete Response Letter on bitopertin and a related shareholder investigation alleging potentially misleading disclosures, raising questions...

On June 1, 2026, a shareholder of New York Times (NYT), the National Center for Public Policy Research, formally demanded access to internal records after a Nicholas Kristof column sparked criticism and legal threats. See our latest analysis for New York Times. The recent activist pressure arrives after a softer near term patch for the stock, with the share price down 6.8% over the past 30 days and 6.1% over 90 days, yet backed by a 34.6% 1 year total shareholder return and a 106.3% 3 year...

PDD Holdings Inc. reported past first-quarter 2026 results with sales of CNY 106,229 million, net income of CNY 12,547 million, and lower basic and diluted earnings per share from continuing operations versus a year earlier. The earnings release highlighted management’s continued heavy investment in supply chain upgrades and Temu’s global expansion, even as profitability softened year over year. Now, we’ll examine how weaker earnings alongside ongoing supply chain and Temu investments affect...

Why the BoxX-NoAF trial update matters for AtriCure stock AtriCure (ATRC) has drawn fresh attention after announcing that its pivotal BoxX-NoAF clinical trial will complete patient enrollment 12 months earlier than planned, raising questions about what earlier data could mean for the stock. See our latest analysis for AtriCure. The BoxX-NoAF update has arrived at a time when AtriCure’s share price has fallen 31.46% year to date and its 1 year total shareholder return is down 21.26%, pointing...

Grand Canyon Education recently disclosed that it is in discussions with Grand Canyon University to amend their Master Services Agreement, potentially extending the partnership by eight years and revising how service fees are calculated. This contract review matters because it could reshape Grand Canyon Education’s revenue mix, concentration risk, and long-term reliance on its largest university partner. We’ll now examine how the potential eight-year extension of the Grand Canyon University...

In May 2026, Tandem Diabetes Care filed a US$47.40 million shelf registration for 3,260,000 common shares linked to its employee stock ownership plan and separately secured CE mark approval in Europe to extend use of its t:slim X2 and Tandem Mobi automated insulin delivery systems to pregnancy in type 1 diabetes and adults with type 2 diabetes. This broader European certification opens access to new patient groups and care settings, potentially reinforcing Tandem’s role within integrated...

MongoDB (MDB) recently reported first quarter results and raised its full year 2027 revenue and earnings guidance, even as higher for longer interest rate expectations pressured growth stocks in broader trading. See our latest analysis for MongoDB. MongoDB's share price has been volatile recently, with a 7 day share price return down 12.71%, yet a 30 day share price return of 17.73% and a 90 day share price return of 30.31% hinting at rebuilding momentum despite a year to date share price...

In recent weeks, TD SYNNEX and its partners announced new distribution agreements that add the Ramp spend-management platform and ConnectSecure’s cybersecurity and compliance tools to TD SYNNEX’s channel, expanding access for resellers, managed service providers, and enterprise IT buyers. By bringing fintech and security vendors onto its extensive partner network with flexible, low-commitment billing options, TD SYNNEX is positioning itself as a broader one-stop hub for customers looking to...

Avis Budget Group recently completed a US$301.5 million offering of 8.000% senior unsecured notes due 2031 and appointed long-time insider Tina Goldenberg as Chief Accounting Officer, succeeding retiring CAO Cathleen DeGenova, who will advise through April 2027 to support an orderly transition. The combination of fresh fixed-income funding and continuity-focused leadership changes may influence how investors view Avis Budget Group’s balance sheet, reporting oversight and longer-term...

GLOBALFOUNDRIES (GFS) has drawn fresh attention after two new alliances linked its foundry platform to U.S. Department of Energy Genesis Mission researchers and to silicon photonics partner Sivers Semiconductors targeting AI data center connectivity. See our latest analysis for GLOBALFOUNDRIES. These alliances arrive as GLOBALFOUNDRIES trades at US$77.31, with a 90 day share price return of 65.79% and a 1 year total shareholder return of 101.38%, pointing to strong recent momentum despite...

Onto Innovation (ONTO) is back in focus after announcing a collaboration with Rigaku that includes acquiring a 27% stake, alongside stronger than expected first quarter results and fresh attention from Artisan Partners. See our latest analysis for Onto Innovation. Those Rigaku and Q1 updates arrived alongside a 6.22% 1 day share price return and a 62.17% year to date share price return, while the 1 year total shareholder return of 170.45% and 5 year total shareholder return of 259.61% point...

Stock performance snapshot and recent moves MillerKnoll (MLKN) has drawn investor attention after a period of weaker share performance, with the stock down about 2% on the day, 6% over the past week and 11% over the past month. See our latest analysis for MillerKnoll. At a share price of $14.52, MillerKnoll’s recent 1-day, 7-day, and 30-day share price returns highlight fading short term momentum, while the 3-year total shareholder return of 11.85% contrasts with a much weaker 5-year total...

Visteon Corporation recently announced that its 12.3-inch Narrow Border Driver Display is featured in the newly launched Lexus ES, marking a premium in-cabin technology application with an ultra-slim, high-brightness LCD panel and advanced optical bonding for improved clarity and reduced glare. This Lexus program also represents a manufacturing milestone for Visteon in Thailand, where full in-house display construction and optical bonding strengthen end-to-end production control across its...

Recent share performance and business scale Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has seen its stock decline 14.7% year to date, while the past 3 months show a gain of 4.4% and the month is broadly flat. For context on the underlying business, the company reports revenue of roughly $850,476.19 and net income of about $36,113.48. Its operations span cement, concrete, aggregates, railway services and other related activities in Argentina. See our latest analysis for...